Lifanxing ribosomycin sulfate main function

Lifanxing ribosomycin sulfate is an injection. Its indications are the treatment of Escherichia coli and hemophilic influenza. It also has a good therapeutic effect on Klebsiella pneumoniae and Shigella. It is often used for respiratory tract infections, urinary system and biliary tract infections. It is injected intramuscularly. During treatment, attention should be paid to the course of treatment, which should not exceed 14 days. A small number of patients will experience some adverse reactions.

Lifanxing ribosomycin sulfate main function

Functions and indications: The antibacterial spectrum is similar to that of kanamycin. It is effective against Staphylococcus, Streptococcus, Pneumococcus, Escherichia coli and some strains of Proteus. The antibacterial effect is stronger than kanamycin, but slightly weaker. This product is ineffective against Pseudomonas aeruginosa and Pseudomonas aeruginosa. Bacteria have a certain cross-resistance to this product and kanamycin. Medical Education | The website collects clinically used drugs for infections of the respiratory tract, abdominal cavity, chest cavity, urinary tract, skin and soft tissue, bone tissue, as well as eyes, ears and nose caused by sensitive Gram-negative bacilli.

Dosage

Intramuscular injection. Adults: 0.5g to 0.75g (1 to 1.5 tablets) at a time, twice a day. For children, the dose is 20-40 mg/kg per day, divided into 2 injections. The course of treatment is generally within 10 days and no more than 14 days.

Adverse Reactions

Occasionally, there may be rash, numbness, tinnitus, headache, nausea, vomiting, diarrhea, etc. Some patients may also experience hearing loss, dizziness, vitamin B12 or vitamin B12 deficiency, increased blood urea nitrogen and blood aminotransferase, etc. Shock has been reported occasionally.

Taboo

1. It is contraindicated for patients with impaired renal function. 2. Pregnant women are prohibited from using this product. 3. Not for use by infants and young children.

Precautions

1. Cross-allergy: patients who are allergic to other aminoglycosides may also be allergic to this product. 2. The drug should be used with caution in the following situations: (1) dehydration, which may increase the possibility of toxic reactions due to increased blood drug concentration; (2) damage to the 8th cranial nerve, which may cause damage to the auditory nerve and vestibular function; (3) myasthenia gravis or Parkinson's disease, which may cause neuromuscular blockade and lead to skeletal muscle weakness; (4) renal impairment, in which case the dose or dosing interval should be adjusted according to the degree of renal impairment. 3. Interference with diagnosis: It may increase the measured values ​​of alanine aminotransferase, aspartate aminotransferase, serum bilirubin concentration and serum lactate dehydrogenase concentration; the measured values ​​of blood calcium, blood magnesium, blood potassium and blood sodium concentration may decrease. 4. Patients should be monitored: (1) Vestibular function tests, to detect vestibular toxicity before and regularly during medication, and after long-term medication; (2) Urinalysis and renal function tests, to test renal function before and regularly during medication to prevent severe renal toxicity reactions.